Related Experiment Video
Updated: Aug 4, 2026
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
[Screening for alpha 1-antitrypsin deficiency in neonates]
M Durpektová1, L Kozák, A Mrskos
1Výzkumný ústav zdraví dítĕte, Brno.
Insights
This study screened over 113,000 children for alpha-1-antitrypsin deficiency using an affordable method, revealing a low incidence in the Czechoslovak population. Further discussion explores expanding this screening nationwide.
Area of Science:
- Medical screening
- Biochemistry
- Pediatrics
Context:
- Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder.
- Early detection in children is crucial for managing associated health risks.
- Previous AATD screening studies have varied in methodology and population focus.
Purpose:
- To implement and evaluate a cost-effective screening method for AATD in a large pediatric cohort.
- To determine the incidence of AATD in the Czechoslovak population.
- To assess the feasibility of expanding AATD screening nationally.
Summary:
- A two-year screening of 113,274 children identified those with low alpha-1-antitrypsin levels (<1.5 g/l) for phenotype assessment.
- Quantitative assessment in 120 neonates confirmed physiological ranges (1.4-3.32 g/l).
- The study revealed a lower incidence of AATD in Czechoslovakia compared to international data.
Impact:
- Highlights the effectiveness of an economical screening approach for AATD.
- Provides crucial epidemiological data on AATD prevalence in a specific population.
- Informs discussions on the clinical, ethical, and economic viability of nationwide AATD screening programs.
Abstract:
In a two-year investigation 113,274 children were screened for alpha-1-antitrypsin deficiency. An original and cheap method was used. In children with an alpha-1-antitrypsin values lower than 1.5 g/l the phenotype was assessed. In 120 neonates alpha-1-antitrypsin was assessed by screening and also quantitatively. The physiological range of alpha-1-antitrypsin for neonates is: 1.4-3.32 g/l. A low incidence of alpha-1-antitrypsin in the Czechoslovak population, as compared with investigations abroad, was revealed. The authors discuss the possibility to extend screening from the clinical, ethical and economic aspect to the entire republic.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023